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Abstract
Background: It is well established that the immature myocardium preferentially utilises non-oxidative energy-
generating pathways. It exhibits low energy-transfer capacity via the creatine kinase (CK) shuttle, reflected in 
phosphocreatine (PCr), total creatine and CK levels that are much lower than those of adult myocardium. The 
mechanisms leading to gradually increasing energy transfer capacity during maturation are poorly understood. 
Creatine is not synthesised in the heart, but taken up exclusively by the action of the creatine transporter protein (CrT). 
To determine whether this transporter is ontogenically regulated, the present study serially examined CrT gene 
expression pattern, together with creatine uptake kinetics and resulting myocardial creatine levels, in rats over the first 
80 days of age.
Results: Rats were studied during the late prenatal period (-2 days before birth) and 7, 13, 21, 33, 50 and 80 days after 
birth. Activity of cardiac citrate synthase, creatine kinase and its isoenzymes as well as lactate dehydrogenase (LDH) and 
its isoenzymes demonstrated the well-described shift from anaerobic towards aerobic metabolism. mRNA levels of CrT 
in the foetal rat hearts, as determined by real-time PCR, were about 30% of the mRNA levels in the adult rat heart and 
gradually increased during development. Creatine uptake in isolated perfused rat hearts increased significantly from 
3.0 nmol/min/gww at 13 days old to 4.9 nmol/min/gww in 80 day old rats. Accordingly, total creatine content in hearts, 
measured by HPLC, increased steadily during maturation (30 nmol/mg protein (-2 days) vs 87 nmol/mg protein (80 
days)), and correlated closely with CrT gene expression.
Conclusions: The maturation-dependant alterations of CK and LDH isoenzyme activities and of mitochondrial 
oxidative capacity were paralleled by a progressive increase of CrT expression, creatine uptake kinetics and creatine 
content in the heart.
Background
Postnatal maturation of the heart is associated with sub-
stantial changes in energy metabolism, one of the key
determinants of performance. Foetal and newborn hearts
are relatively more dependent on anaerobic glycolysis,
using mostly glucose, whereas the mature heart is almost
exclusively aerobic, with free fatty acids as the predomi-
nant substrate [1,2]. The transition from carbohydrate to
fatty acid metabolism (i.e. anaerobic to aerobic metabo-
lism) is well documented [3,4] and involves processes,
such as maturation of mitochondria and changes in circu-
lating levels of fatty acids and lactate [2]. Thus, the imma-
ture myocardium is characterised by lower mitochondrial
content [5] and lower activities of both tricarboxylic acid
cycle and electron transport chain enzymes [6,7]. Fur-
thermore, contents of both phosphocreatine and total
creatine [8], as well as creatine kinase activity [9-11] show
a monotonic increase during cardiac maturation. Specifi-
cally, myocardial MM-CK and mito-CK isoenzymes
increase [12-15], while relative activities of BB-CK and
MB-CK isoenzymes decrease during maturation [16,17].
Creatine is not synthesised in the heart, but taken up by
cardiomyocytes exclusively by action of the creatine
transporter (CrT), a 55 Kda-plasma membrane protein
[18]. This transporter is likely to be involved in the regu-
lation of creatine content in the cardiomyocyte during
maturation. One recent report focused on regulation of
creatine metabolism during pregnancy in spiny mice [19].
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However, to date, no studies have reported on CrT
expression and function during cardiac maturation in
rats, and in particular, spanning from in utero, through
adolescence, and into adulthood.
Therefore, the present study was designed to serially
examine the mechanisms by which maturation affects
transcription and function of CrT in the heart. For this
purpose, the CrT mRNA levels were measured in rats of
different age using real-time RT-PCR. All currently avail-
able anti-CrT antibodies cross-react with non-CrT poly-
peptides [20] and consequently a reliable evaluation of
CrT protein expression is currently not feasible. There-
fore, creatine transporter function in the developing rat
myocardium was assessed by measuring creatine uptake
by means of perfusing hearts with 14C-creatine.
Results
Heart weight, body weight and cardiac function
Table 1 shows characteristics of rats during 7 stages of
development. During perinatal development, as
expected, there was a progressive increase of heart weight
(HW) and body weight (BW). The heart weight/body
weight ratio decreased significantly from 10.9 ± 2.1 mg
heart/g body weight in fetuses to 3.94 ± 0.1 mg heart/g
body weight in adults (p < 0.001). Heart rate (HR),
obtained in perfused heart experiments (13 days old
onwards) was unchanged over time. Left ventricular
developed pressure (LVDP) was not significantly different
in isolated, buffer-perfused hearts.
Plasma creatine levels, myocardial creatine content and 
cardiac enzyme activities
The mean plasma creatine concentrations, which could
be obtained from 7 day old animals onwards, are also
shown in Table 1. During maturation there was a steady
decrease of up to 44% in plasma creatine concentration
(0.97 ± 0.07 mmol/L (7 days) vs 0.54 ± 0.08 mmol/L (80
days), reaching significance (p < 0.05) from 33 days of age
onwards.
Total creatine content (Figure 1A) in the heart signifi-
cantly (ANOVA p < 0.001) increased during maturation
from 30.1 ± 1.3 nmol/mg protein in -2 day old rats to 87 ±
2.9 nmol/mg protein in 80 day old rats, corresponding to
a ~3-fold increase. Similarly, total creatine kinase (CK)
activity increased several-fold (p < 0.001) during matura-
tion (2.1 ± 0.26 mIU/mg protein (-2 days) vs 8.06 ± 0.4
mIU/mg protein (80 days) (Figure 2)). Compared with
adult heart, B-containing CK isoenzymes are relatively
more abundant in foetal myocardium, but total CK activ-
ity is much lower. Calculating CK isoform activities from
total CK and % isoenzyme distribution revealed that the
BB isoform did not increase until 80 days of age
(ANOVA: p = 0.01), whilst MB- (2.1-fold, p < 0.001) and
MM-isoforms (4.7-fold, p < 0.001) increased directly after
birth. The activity of mito-CK, which was not detectable
until at 13 days after birth, increased during growth from
0.0075 ± 0.05 to 2.68 ± 0.26 mIU/mg protein. Citrate syn-
thase activity, a marker of mitochondrial volume, rose
significantly (p < 0.001) in a steady manner throughout
the perinatal period and reached maximum levels in the
adult of 0.95 ± 0.03 mIU/mg protein.
Figure 3 shows the developmental pattern of total lac-
tate dehydrogenase (LDH) activity. Although no signifi-
cant difference was found in total LDH activity during
maturation, the distribution of LDH isoenzyme activities
changed significantly. LDH1, LDH2 and LDH3 isoenzymes
showed a significant increase (~7.4, ~3.6 and 1.4 fold
respectively), while LDH4  and LDH5  isoenzymes
decreased (~3 and 12.5 fold respectively). This shift in
LDH isoenzyme activity reflects the change from anaero-
bic to aerobic metabolism during maturation.
Creatine transporter gene expression
To explore changes in CrT mRNA expression during
maturation, the total RNA isolated from rat hearts of dif-
ferent age groups was analyzed using a real-time quanti-
tative RT-PCR technique. The abundance of the
transcripts for CrT increased steadily with age (Figure
1B). At 80 days of age, cardiac mRNA levels of CrT were
significantly higher compared with all other experimental
groups, showing a ~3.6 fold higher relative expression of
CrT as compared to -2 day old rats (ANOVA p < 0.001).
Creatine uptake
CrT function was examined by measuring creatine
uptake by means of 14C creatine labeled heart perfusion.
Table 1 shows the rate of creatine uptake at 500 μmol/L
extracellular creatine in 13 to 80 day old rats. Creatine
uptake steadily increased with age and was significantly
higher than in 13 day old hearts from day 50 onwards.
Creatine uptake was 3.0 ± 0.6 nmol/min/gww in the 13
day old heart and reached 4.9 ± 0.5 nmol/min/gww at 80
days of age, i.e. increased by ~65%. Thus, creatine con-
tent, CrT expression and CrT function all increased
steadily during maturation.
Correlations of creatine content and uptake with gene 
expression
There was a significant correlation (r2 = 0.70, p < 0.001)
between CrT mRNA and total creatine levels (Figure 4A)
as well as CrT mRNA and creatine uptake (r2 = 0.90, p <
0.001, Figure 4B).
Discussion
To the best of our knowledge, this is the first study to
examine changes in myocardial creatine transporter
(CrT) mRNA levels, creatine uptake and content during
cardiac maturation, which includes the pre-natal periodFischer et al. BMC Developmental Biology 2010, 10:70
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(-2 d), early postnatal period (7 d, 13 d), the immediate
post-weaning period (21 d, 33 d), and the period of sexual
maturity (50 d) and adult life (80 d).
Changes of substrate utilisation and myocardial energetics 
during maturation
The velocity of the CK reaction changes with the size of
the creatine pool and also with the accumulation of CK
isoenzymes and the shift in isoenzyme distribution [14].
The appearance of CK function in myofibrils and mito-
chondria during maturation has been studied in a num-
ber of animal models [16,12,9,10]. In agreement with
previous studies [13,14], we showed that mito-CK, bound
on the inner membrane of the mitochondria, and MM-
CK, a significant portion localised at sites of ATP utilisa-
tion, e.g. myofibrils, are the predominant isoenzymes in
mature myocardium, whereas BB-CK and MB-CK isoen-
zymes dominate in the immature myocardium. Adult lev-
els of mito-CK are not reached until late in development
(50 days), suggesting that its role in mediating PCr syn-
thesis from oxidative phosphorylation is required at a rel-
atively late stage of maturation. These findings confirm
previous results and show that the maturational changes
in creatine metabolism described occur in parallel to the
expected changes in the creatine kinase system.
In line with previous studies [17], total creatine content
in hearts increased 3-fold during maturation. Recent
findings from Ireland et al [19] in the spiny mouse, which,
unlike conventional rats and mice, has a long gestation of
38-40 days, revealed that the estimated amount of total
creatine did not change in the foetal heart between 30-37
days gestation, but it increased significantly by postnatal
day 10. In the fetus, myocardial creatine is derived both
from the mother and from de novo synthesis. During
maturation myocardial creatine levels increase as the
demand for all energy-requiring processes in the heart
rises. Likewise, myofibrillar ATPase activity increases
steadily during the perinatal period [12]. Thus, energy
producing and energy utilising reactions are concomi-
tantly increased within the cardiomyocyte.
Alterations of LDH isoform expression and citrate synthase 
activity
In our study, changes in total LDH activity were accom-
panied by distinct changes in LDH isoenzyme pattern.
Specifically, we observed an increase in LDH1, LDH2 and
LDH3 isoenzymes. LDH1 and LDH2 were predominant in
the adult heart, whilst LDH4 and LDH5 were found to
dominate in the foetal heart. These changes are again in
line with previous findings [21] and are indicative of the
Table 1: Heart weights (HW), body weights (BW), cardiac function, plasma creatine content and creatine uptake during 
development in the rat heart
Age (days) -2 ( fetal ) 7 13 21 33 50 80 ANOVA
HW (g) 0.039 ± 0.01a 0.13 ± 0.01b 0.17 ± 0.06bc 0.24 ± 0.03c 0.44 ± 0.04d 0.70 ± 0.07e 1.17 ± 0.02f p < 0.001
[4] [4] [7] [5] [8] [6] [8]
BW (g) 3.59 ± 0.34a 22.0 ± 1.78b 35.6 ± 7.08c 41.5 ± 4.1c 78.6 ± 2.4d 178 ± 8.6e 296 ± 5.3f p < 0.001
[4] [4] [7] [5] [8] [6] [8]
HW/BW *1000 10.9 ± 2.1a 5.79 ± 0.80ab 4.81 ± 1.15ab 5.84 ± 0.70a 5.58 ± 0.47a 3.93 ± 0.32b b 3.94 ± 0.10b p < 0.001
[4] [4] [7] [5] [5] [6] [8]
HR (bpm) - - 321 ± 5.7 248 ± 4.9 348 ± 5.6 318 ± 34 307 ± 45 NS
[4] [4] [4] [4] [4]
LDVP (mm Hg) - - 69 ± 12.7 88.6 ± 0.36 65.7 ± 7.2 75.7 ± 10.2 97.1 ± 27.6 NS
[4] [4] [4] [4] [4]
RPP (mm Hg/bpm) - - 22129 ± 3673 22047 ± 555 22879 ± 2874 24189 ± 5524 29673 ± 8913 NS
[4] [4] [4] [4] [4]
Creatine uptake -- 3.03 ± 0.55a 3.66 ± 0.79ab 3.85 ± 0.62abc 4.68 ± 0.54bc 4.99 ± 0.52c p < 0.001
(nmol/min/g w.w) [6] [5] [5] [5] [6]
Plasma creatine - 0.971 ± 0.07a 0.669 ± 0.16ab 0.678 ± 0.19ac 0.627 ± 0.12bc 0.558 ± 0.06bc 0.536 ± 0.08bc p = 0.002
(mmol/L) [4] [4] [4] [4] [4] [4]
Data are presented as means ± S.E and sample size are given in brackets. Values within a row with different superscript letters are significantly 
different to all other time points (p < 0.05, creatine uptake, plasma creatine: Bonferroni; HW, BW, HW/BW*1000: Dunnett T3, ANOVA "test for linear 
trend": as indicated).
NS = not significant, p > 0.05Fischer et al. BMC Developmental Biology 2010, 10:70
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shift from anaerobic to aerobic metabolism during matu-
ration.
Similarly, citrate synthase, a marker of mitochondrial
volume, increased during maturation. A rise in mito-
chondrial numbers is consistent with previous studies
[22] and reflects the increased energy demand of mature
myocardium.
Regulation of creatine uptake and creatine transporter 
expression during maturation
Studies using cultured cells [23-25], isolated rat hearts
[26] and in vivo human studies [27] indicate that muscle
cells tightly regulate their intracellular creatine content.
However, the underlying cellular and molecular mecha-
nisms by which these cells perform this task are only par-
tially understood. The two enzymes required for creatine
biosynthesis L-arginine:glycine amidinotransferase and
S-adenosylmethionine:N-guanidinoacetate methyltrans-
ferase [28] may be expressed in heart tissue [29], but
activities of these enzymes are negligible and therefore
creatine is not synthetised in heart muscle in significant
amounts. Instead, creatine is taken up into the heart by
the action of the creatine transporter. During maturation,
cardiac creatine levels increase steadily. Therefore, we
hypothesized that during development the CrT-governed
creatine uptake is progressively increased.
Indeed, we found the maximal rate of creatine trans-
port to steadily increase during maturation, in parallel
with both total creatine content and creatine transporter
mRNA levels. Importantly, we found a significant correla-
tion (r2 = 0.70) between CrT mRNA and total creatine
levels as well as CrT mRNA and creatine uptake (r2 =
0.90). Thus during development, 90% of the total variance
in creatine uptake capacity and 70% of the variance in
creatine content could be explained by changes in gene
expression of the CrT. This is in contrast to the adult
heart, where changes in CrT activity in response to
genetically altered creatine content were mainly driven by
non-transcriptional means, e.g. substrate feedback or
post-translational modification [30].
The near maximum rate for 14C-creatine uptake in iso-
lated perfused 80 day old rat hearts (4.99 ± 0.52 nmol/
min/gww) agreed with previously published data on adult
rat heart [31,26,32]. The observed increase in heart
weight does not explain the observed maturation-
induced increase in Na+/Cl- creatine transport activity
because the uptake values were normalised to mg of pro-
tein. Likewise, Garcia-Delgado et al [33] found an up-reg-
ulation of renal Na+/Cl-  creatine transporter during
ontogeny in rats. In their study, age increased Vmax, indi-
cating that renal maturation may have increased the den-
sity of creatine transporters and/or their turnover rate.
Similar to our findings, Braissant et al [34] showed
detectable CrT mRNA levels in the rat embryo at 18.5 day
of gestation, while at day 12.5 and 15.5, mRNA levels
were absent. Ireland et al [19] recently demonstrated in
the spiny mouse that, between gestational day 37 and
postnatal day 10, cardiac mass increased almost 3-fold
and total creatine content increased 2-fold. CrT mRNA
expression, however, did not increase significantly
between mid-gestation and gestational day 37 and stayed
at similar levels until postnatal day 10. Thus, the authors
suggest that creatine uptake into the heart is facilitated by
a n  i n c r e a s e  i n  C r T  a c t i v i t y  r a t h e r  t h a n  C r T  p r o t e i n
expression. In contrast, we found a significant increase of
CrT mRNA expression in the rat heart at day 13 com-
pared to pre-gestation (-2 days).
The reason for decreasing plasma concentration of Cr
at different ages may be related to the fact that Cr accu-
mulates in several organs and tissues (e.g. heart, brain
[35] and skeletal muscle [36] at later stages of develop-
ment, likely trough an increase in Cr uptake. Higher
uptake may in turn lead to lower Cr levels in the plasma
as observed in the present study. In fact, for the heart we
have found an inverse relationship (r2 = 0.588, p < 0.05)
Figure 1 Total creatine content and creatine transporter mRNA in 
rat heart during maturation. A). Myocardial total creatine content in 
rats aged -2, 7, 13, 21, 33, 50 and 80 day old. B) Creatine transporter 
(CrT) mRNA levels in rat heart during maturation. Total RNA was isolat-
ed from foetal hearts on day 20 of gestation (2 d before birth), and 7, 
21, 33, 50 and 80 d after birth. The level of CrT mRNA was measured by 
real-time RT-PCR and normalized to β-actin. Values are mean ± S.E. and 
sample size are given in brackets on the labels of the X axis. Data points 
not sharing the same superscript letter indicate total creatine and 
mRNA level respectively are significantly different to all others (p < 0.05 
Bonferroni, ANOVA "test for linear trend": p < 0.001).
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Figure 2 Total creatine kinase (CK) and its isoenzyme activities and citrate synthase (CS) activity during maturation. Values are means ± S.E. 
and sample size are given in brackets on the labels of the X axis. Data points with different superscript letters are significantly different to all other 
timepoints (p < 0.05, CK, CS: Bonferroni; Mito-CK, MM-CK, MB-CK, BB-CK: Dunnett T3, ANOVA "test for linear trend": as indicated).
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between plasma Cr and CrT gene expression. A decrease
in intestinal Cr uptake during development [37] may add
to this phenomenon of decreasing plasma concentration.
Furthermore, phosphorylation of CrT by cAMP-depen-
dent protein kinase A and protein kinase C, which affect
CrT activity, may be an underlying signal transduction
pathway by which the CrT in heart is regulated during
early development after birth as suggested by others [37].
Limitations
Unfortunately, to date it remains impossible to determine
how the increases in CrT mRNA, activity and creatine
content are paralleled by an increase in CrT protein con-
tent, since all available anti-CrT antibodies cross-react
with pyruvate dehydrogenase and other proteins [20].
Therefore, determining the changes in CrT protein
expression during development including post-transla-Fischer et al. BMC Developmental Biology 2010, 10:70
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Figure 3 Total lactate dehydrogenase (LDH) and its isoenzyme activities during maturation. Values are means ± S.E. and sample size are given 
in brackets on the labels of the X axis. Data points with different superscript letters are significantly different to all other timepoints (p < 0.05, LDH1, 
LDH2, LDH3, LDH4: Bonferroni; LDH5: Dunnett T3, ANOVA "test for linear trend": as indicated).
Note: NS = not significant, p > 0.05
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tional regulatory mechanisms remains an important
milestone for the future. Another limitation of our study
is that we did not perform measurements of high-energy
phosphate metabolites ATP, phosphocreatine, and of the
free energy change of ATP hydrolysis (delta-G). However,
on wet chemical analysis, phosphocreatine is highly
unstable and it would be a challenge to measure this reli-
ably in the smallest hearts. Furthermore, delta-G requires
measurement of intracellular pH by 31P-MRS in isolated
perfused hearts, which is currently not technically possi-
ble in the youngest age groups. These analyses are impor-
tant goals for future research.
Conclusions
Our work shows that the typical alterations of CK and
LDH isoenzymes and of mitochondrial oxidative capacity
observed during heart maturation are paralleled by a pro-
gressive increase of creatine uptake kinetics. Moreover,Fischer et al. BMC Developmental Biology 2010, 10:70
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CrT mRNA in rat heart increased steadily during matura-
tion and this increase was reflected by the myocardial
creatine content. Our data suggest that the age-depen-
dent increase in the activity of the PCr/CK system is
closely paralleled by increases in CrT mRNA expression,
Cr uptake and cardiac Cr content, reflecting the increas-
ing requirement of the heart for ATP turnover over the
first 80 days of life.
Methods
Experimental animals
All experimental procedures in this study were approved
by the University of Oxford Animal Ethics Review Com-
mittees and by the Home Office (London, U.K). Rats used
in all studies were of the Wistar strain. Timed pregnant
rats were obtained from a commercial breeder (Harlan,
U.K) and kept under controlled conditions for tempera-
ture, humidity and light, with creatine-free rat chow and
water available ad libitum. Pups were weaned at 21 days
and placed on the same chow as the mother. Fetuses at 18
days after gestation (-2 days) were obtained by Caesarean
section after anesthetising the mother with 1.5-2% isoflu-
rane. Animals of age 7, 13, 21, 33, 50 and 80 days were
used.
Heart preparation
Animals were anesthetized with an intraperitoneal injec-
tion of 75 mg/kg body wt sodium pentobarbitone (Saga-
tal, Rhône Mérieux, Dublin), whilst foetuses were
sacrificed by cervical dislocation. After loss of pedal
reflexes, blood samples were removed from the femoral
vein (animals aged 7 days onwards) and hearts were rap-
idly excised and arrested in ice-cold Krebs-Henseleit buf-
fer (see below). Hearts from 13, 21, 33, 50 and 80 day old
rats were cannulated via the ascending aorta for retro-
grade perfusion radiolabelled 14C-creatine transport
studies and metabolite assays (-2 and 7 day old hearts
were too small for perfusion). A water-filled cling film
balloon, attached via polytetrafluorethylene tubing to a
Gould disposable pressure transducer, was inserted into
the left ventricular cavity via the mitral valve, secured by
a ligature and inflated sufficiently to give an end-diastolic
pressure (EDP) of ~4 mm Hg. Heart rate and left ventric-
ular (LV) pressures were recorded continuously using a
MacLab 4a (AD Instruments Ltd, Hastings, UK) linked to
Chart™ software (AD Instruments).
Radioactive creatine uptake assays
Hearts from > 13 days old rats (different from the rats
used for the biochemical analysis, which in our setup is
not possible on radioactive samples) were perfused with
Krebs-Henseleit (KH) buffer containing (mmol/L) NaCl
(110), KCl (4.7), MgSO4.7H2O (1.2), CaCl2.2H2O (1.75),
glucose (11), KH2PO4 (2), NaHCO3 (25), Na2EDTA (0.5),
Na-Lactate (0.5) and Na-Pyruvate (4.5). The buffer, sup-
plemented with 500 μmol/L creatine, was gassed with
95% O2/5% CO2 to give a pH of 7.4 at 37°C. Creatine con-
centration was used at the optimal level of 500 μmol/L,
since Cr uptake by adult rat hearts at this concentration,
approaches Vmax [26,31]. Hearts were perfused with a
recirculating volume of ca. 400 ml at a constant pressure
of 100 mmHg. Cardiac contractile function was moni-
tored throughout the protocol as described above. Since
the accumulation of 14C-labelled creatine in the heart has
been shown to be linear throughout a 1 hr incubation
[26], 30 minutes was used as the optimal radioactive label
perfusion time. Hearts were allowed to equilibrate for 10
min and then 14C-labelled creatine (Apin Chemicals Ltd,
Abingdon, U.K) was added in trace amounts to the recir-
culating buffer. Hearts were perfused in the presence of
14C-creatine for 30 minutes, after which time a final 15
min label washout period followed, using a non-circulat-
ing mode with non-radioactive buffer. The absence of
14C-label in the effluent between 10 and 15 min of wash-
out ensured that the extracellular space had been cleared
and that creatine leakage from the heart was negligible.
At the end of the perfusion protocol, hearts were weighed
Figure 4 Relationship between CrT mRNA and total creatine (A) 
and between CrT mRNA and creatine uptake (B), indicated by 
Pearson's correlation coefficient. Each data point (mean ± S.E.) rep-
resents a different developmental age from -2, 7, 13, 21, 33, 50 and 80 
days post-partum. CrT mRNA and total creatine data were collected 
from the same hearts, whereas creatine uptake data was collected 
from different hearts. There are no data points in (B) for days -2 and 7 
since it was not possible to measure creatine uptake in these very small 
hearts.
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and scar tissue removed. Subsequently, hearts were
digested in 1 ml of 1 M KOH at 60°C before scintillation
counting for [14C] as described previously [26].
RNA isolation and creatine transporter mRNA expression
Total RNA was extracted from frozen heart tissue using
the RNeasy Kit (Qiagen), including treatment with pro-
teinase K according to manufacturer's instructions. Total
tissue RNA dissolved in RNase-free water was used in
real-time RT-PCR (Qiagen Quantitect SYBR Green
RTPCR kit, Qiagen, Crawley, United Kingdom), along
with the following primers: RT-CrT-F 5'-gccggcagcat-
caatgtc-3', RT-CrT-R 5'-ggtgttgcagtagaagacgatcac-3'.
Quantitative fluorescent real-time RT-PCR analysis was
performed to investigate mRNA expression levels in rat
hearts of different age using the Rotor-Gene system (Cor-
bett Research Ltd., Cambridge, United Kingdom). To
demonstrate linearity of the reactions, a standard curve
was generated using a series of total RNA dilutions from
80-day-old rat hearts. Results were normalized to the
expression levels of the housekeeping gene β-actin
(RTactinF 5'-gacaggatgcagaaggagattact-3', RTactinR 5'-
tgatccacatctgctggaaggt-3'). Real-time RT-PCR was per-
formed in duplicate with 8-10 ng of total RNA as input.
Quantification was carried out using appropriate soft-
ware to generate standard curves, which expressed rela-
tive quantities of PCR products in the experimental
samples in arbitrary units relative to the standard curve.
Plasma preparation
Total blood samples were centrifuged at 3,000 rpm for 10
min. The supernatant was used for the determination of
plasma concentrations of creatine by HPLC as previously
described [38].
Myocardial enzymes and creatine measurements
Hearts were perfused for 10 minutes before being rapidly
freeze-clamped using Wollenberger tongs. Aliquots were
taken to measure protein content by the method of
Lowry [39]. 0.1% Triton X was added and enzyme activi-
ties of citrate synthase, CK and LDH were measured
using an Ultraspec 2100 pro (Pharmacia Biosystems) as
previously described [37]. CK isoenzyme distribution was
measured using the Rapid Electrophoresis System (REP,
Helena Biosciences, UK) as a separation unit, and the
REP CK isoforms kit (Helena Biosciences, UK). For mea-
surements of LDH isoenzymes, the Titan Gel LD Isoen-
zyme System (REP, Helena Biosciences, UK) was used.
The Electrophoresis Data Center (EDC, Helena Biosci-
ences, UK) automatically quantified the separated isoen-
zyme band. For HPLC analysis, tissue was homogenised
in 0.4 N perchloric acid at 4°C, neutralised and centri-
fuged for 5 min at maximum speed, at 4°C. The superna-
tant was used to measure total creatine levels as
previously described [40]. Tissue concentrations were
expressed in nmol/mg of protein.
Statistical analysis
Data are expressed as the mean ± SE and sample size is
given in brackets. To determine statistical significance
between age groups, test for linear trend in one way anal-
ysis of variance (ANOVA) was performed, followed by a
Bonferroni multiple comparison test. Every time point
was compared with every other time point. In case of
inhomogeneity of variance the Dunnet T3 test was used.
P values less than 0.05 were considered significant. Cor-
relation analysis was conducted for selected variables. All
statistical analyses were performed by SPSS (Version
13.0).
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